Literature DB >> 24900351

Bivalent Ligands for the Serotonin 5-HT3 Receptor.

Andrea Cappelli1, Monica Manini1, Marco Paolino1, Andrea Gallelli1, Maurizio Anzini1, Laura Mennuni2, Marta Del Cadia3, Francesca De Rienzo4, M Cristina Menziani3, Salvatore Vomero1.   

Abstract

The serotonin 5-HT3 receptor is a ligand-gated ion channel, which by virtue of its pentameric architecture, can be considered to be an intriguing example of intrinsically multivalent biological receptors. This paper describes a general design approach to the study of multivalency in this multimeric ion channel. Bivalent ligands for 5-HT3 receptor have been designed by linking an arylpiperazine moiety to probes showing different functional features. Both homobivalent and heterobivalent ligands have shown 5-HT3 receptor affinity in the nanomolar range, providing evidence for the viability of our design approach. Moreover, the high affinity shown by homobivalent ligands suggests that bivalency is a promising approach in 5-HT3 receptor modulation and provides the rational basis for applying the concepts of multivalency to the study of 5-HT3 receptor function.

Entities:  

Keywords:  5-HT3; Serotonin receptors; bivalent ligands; molecular modeling; multivalency

Year:  2011        PMID: 24900351      PMCID: PMC4018136          DOI: 10.1021/ml2000388

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  15 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Computational analysis of ligand recognition sites of homo- and heteropentameric 5-HT3 receptors.

Authors:  Arménio J Moura Barbosa; Francesca De Rienzo; Maria J Ramos; Maria Cristina Menziani
Journal:  Eur J Med Chem       Date:  2010-07-27       Impact factor: 6.514

Review 3.  The 5-HT3 receptor as a therapeutic target.

Authors:  Andrew J Thompson; Sarah C R Lummis
Journal:  Expert Opin Ther Targets       Date:  2007-04       Impact factor: 6.902

4.  Further studies on the interaction of the 5-hydroxytryptamine3 (5-HT3) receptor with arylpiperazine ligands. development of a new 5-HT3 receptor ligand showing potent acetylcholinesterase inhibitory properties.

Authors:  Andrea Cappelli; Andrea Gallelli; Monica Manini; Maurizio Anzini; Laura Mennuni; Francesco Makovec; M Cristina Menziani; Stefano Alcaro; Francesco Ortuso; Salvatore Vomero
Journal:  J Med Chem       Date:  2005-05-19       Impact factor: 7.446

5.  Cation-pi interactions in ligand recognition by serotonergic (5-HT3A) and nicotinic acetylcholine receptors: the anomalous binding properties of nicotine.

Authors:  Darren L Beene; Gabriel S Brandt; Wenge Zhong; Niki M Zacharias; Henry A Lester; Dennis A Dougherty
Journal:  Biochemistry       Date:  2002-08-13       Impact factor: 3.162

Review 6.  5-HT3 receptors.

Authors:  A J Thompson; S C R Lummis
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

Review 7.  Molecular biology of 5-HT receptors.

Authors:  Jason Hannon; Daniel Hoyer
Journal:  Behav Brain Res       Date:  2008-03-25       Impact factor: 3.332

Review 8.  The Interactions of the 5-HT(3) receptor with arylpiperazine, tropane, and quinuclidine ligands.

Authors:  Andrea Cappelli; Maurizio Anzini; Salvatore Vomero; Laura Mennuni; Francesco Makovec; Michel Hamon; Pier G De Benedetti; M Cristina Menziani
Journal:  Curr Top Med Chem       Date:  2002-06       Impact factor: 3.295

9.  The role of tyrosine residues in the extracellular domain of the 5-hydroxytryptamine3 receptor.

Authors:  Kerry L Price; Sarah C R Lummis
Journal:  J Biol Chem       Date:  2004-03-03       Impact factor: 5.157

10.  Functional group interactions of a 5-HT3R antagonist.

Authors:  Padmavati Venkataraman; Prasad Joshi; Srinivasan P Venkatachalan; Mani Muthalagi; Harish S Parihar; Karen S Kirschbaum; Marvin K Schulte
Journal:  BMC Biochem       Date:  2002-06-13       Impact factor: 4.059

View more
  7 in total

1.  Multivalent ligands for the serotonin 5-HT4 receptor.

Authors:  Federica Castriconi; Marco Paolino; Alessandro Donati; Germano Giuliani; Maurizio Anzini; Laura Mennuni; Chiara Sabatini; Marco Lanza; Gianfranco Caselli; Francesco Makovec; Maria Sbraccia; Paola Molinari; Tommaso Costa; Andrea Cappelli
Journal:  Medchemcomm       Date:  2017-02-09       Impact factor: 3.597

Review 2.  Multivalent Inhibitors of Channel-Forming Bacterial Toxins.

Authors:  Goli Yamini; Ekaterina M Nestorovich
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

3.  Development of subnanomolar-affinity serotonin 5-HT4 receptor ligands based on quinoline structures.

Authors:  Federica Castriconi; Marco Paolino; Giorgio Grisci; Cinzia Maria Francini; Annalisa Reale; Germano Giuliani; Maurizio Anzini; Gianluca Giorgi; Laura Mennuni; Chiara Sabatini; Marco Lanza; Gianfranco Caselli; Andrea Cappelli
Journal:  Medchemcomm       Date:  2018-07-03       Impact factor: 3.597

4.  Approaching the 5-HT₃ receptor heterogeneity by computational studies of the transmembrane and intracellular domains.

Authors:  Marta Del Cadia; Francesca De Rienzo; Maria Cristina Menziani
Journal:  J Comput Aided Mol Des       Date:  2013-06-16       Impact factor: 3.686

5.  2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts.

Authors:  Amy Hauck Newman; Francisco O Battiti; Alessandro Bonifazi
Journal:  J Med Chem       Date:  2019-09-24       Impact factor: 7.446

6.  Two for the Price of One: Heterobivalent Ligand Design Targeting Two Binding Sites on Voltage-Gated Sodium Channels Slows Ligand Dissociation and Enhances Potency.

Authors:  Alicia Peschel; Fernanda C Cardoso; Andrew A Walker; Thomas Durek; M Rhia L Stone; Nayara Braga Emidio; Philip E Dawson; Markus Muttenthaler; Glenn F King
Journal:  J Med Chem       Date:  2020-10-20       Impact factor: 7.446

Review 7.  Discriminating between 5-HT₃A and 5-HT₃AB receptors.

Authors:  A J Thompson; S C R Lummis
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.